Barclays’s Organigram Holdings OGI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1 Hold
1
﹤0.01% 4998
2025
Q4
$2 Sell
1
-1,700
-100% -$2.92K ﹤0.01% 5180
2025
Q3
$3.45K Buy
1,701
+1,700
+170,000% +$2.67K ﹤0.01% 5112
2025
Q2
$1 Hold
1
﹤0.01% 5199
2025
Q1
$1 Hold
1
﹤0.01% 5230
2024
Q4
$2 Hold
1
﹤0.01% 5241
2024
Q3
$2 Sell
1
-9,375
-100% -$16.3K ﹤0.01% 5258
2024
Q2
$14.4K Sell
9,376
-1,500
-14% -$2.72K ﹤0.01% 4486
2024
Q1
$23.4K Sell
10,876
-600
-5% -$1.16K ﹤0.01% 4738
2023
Q4
$15K Buy
11,476
+1
+0% +$1 ﹤0.01% 4937
2023
Q3
$15.1K Buy
11,475
+600
+6% +$904 ﹤0.01% 4230
2023
Q2
$67.9K Buy
10,875
+1,000
+10% +$1.93K ﹤0.01% 3716
2023
Q1
$25.3K Buy
9,875
+3,500
+55% +$11.1K ﹤0.01% 4612
2022
Q4
$20.4K Buy
6,375
+675
+12% +$2.54K ﹤0.01% 4807
2022
Q3
$20K Buy
5,700
+4,700
+470% +$19.7K ﹤0.01% 4064
2022
Q2
$4K Buy
1,000
+715
+251% +$3.65K ﹤0.01% 4818
2022
Q1
$2K Buy
+285
New +$1.76K ﹤0.01% 4789
2021
Q3
Sell
-1,800
Closed -$21K 4926
2021
Q2
$21K Sell
1,800
-1,706
-49% -$19.4K ﹤0.01% 4481
2021
Q1
$49K Buy
+3,506
New +$40.5K ﹤0.01% 4203
2019
Q4
Sell
-1,660
Closed -$23K 6671
2019
Q3
$23K Buy
+1,660
New +$34.9K ﹤0.01% 6179

Other funds holding OGI

Barclays's OGI Position: Q1 2026 in Review

Barclays held its Organigram Holdings (OGI) position steady in Q1 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #4998.

Barclays first reported a position in OGI in Q3 2019 and has held it in 20 quarters since. The position peaked at $67.9K in Q2 2023. 73 funds tracked by Wall St. Rank hold OGI as of Q1 2026.

  • Barclays held 1 share of Organigram Holdings worth $1 as of Q1 2026.
  • Barclays left its Organigram Holdings share count unchanged in Q1 2026.
  • Organigram Holdings made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4998 holding.
  • Barclays first reported a position in Organigram Holdings in Q3 2019 and has held it in 20 quarters since.
  • Barclays's Organigram Holdings position peaked at $67.9K in Q2 2023.
  • 73 funds tracked by Wall St. Rank held Organigram Holdings as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.